Author

S. Eikawa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. M. Lowy· 1 shared C. Lu· 1 shared E. Ruoslahti· 1 shared E. S. Mose· 1 shared K. N. Sugahara· 1 shared K. Suzuki· 1 shared N. Miyamura· 1 shared T. Hurtado de Mendoza· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. M. Lowy

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker

K. Suzuki, Y. Kunisada, N. Miyamura, S. Eikawa, T. Hurtado de Mendoza, E. S. Mose, C. Lu, Y. Kuroda, E. Ruoslahti, A. M. Lowy, K. N. Sugahara

This study identifies αvβ5 integrin as a marker for activated tumor-resident Tregs in PDAC, showing that targeting it enhances immune checkpoint therapy.

bioRxiv · May 24, 2023 · PreprintCancer Biology